Gelonghui, September 11 | Kangzhi Pharmaceutical (300086.SZ) announced that on September 6, 2024, Hainan was hit by the 11th super-strong typhoon “Mao” of this year. Kangzhi Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) is located at its Hainan production base in Haikou. Some assets were lost due to the combined effects of this typhoon and torrential rain.
As of the announcement disclosure date, the company's resumption of work is progressing in an orderly manner. Currently, the company has sufficient stocks. The disaster has not affected the company's normal supply and sales, but due to damage to the plant, machinery and equipment, etc., it has had a certain impact on the normal production of the company's workshop.
Due to network instability, it will take a certain amount of time to investigate and check the data. According to the company's preliminary estimates, the company's asset loss due to the typhoon disaster is estimated to be around 30 million yuan (without considering deducting the insurance company's subsequent compensation amount; the company has already purchased some property insurance, and the insurance company is measuring the damage). The specific loss amount is based on the company's financial report after the audit.
At present, the company's water and electricity have been supplied normally, and the company's management is actively organizing various post-disaster repairs such as inspection and testing machinery and equipment, in an effort to resume production as soon as possible.
